Incyte Corporation
ANTI-CD73 ANTIBODIES AND USES THEREOF
Last updated:
Abstract:
Anti-CD73 antibodies are disclosed. Also disclosed are related nucleic acids, vectors, cells, and pharmaceutical compositions. Methods of treating cancer with the anti-CD73 antibodies are also disclosed.
Status:
Application
Type:
Utility
Filling date:
30 Dec 2020
Issue date:
29 Jul 2021